Skip to main content
logo
Herantis Pharma Oyj (HEL:HRTIS)
Finland flag Finland · Delayed Price · Currency is EUR
1.650
+0.030 (1.85%)
Aug 28, 2026, 6:29 PM EET

Herantis Pharma Oyj Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
444931322827
Market Cap Growth
3.12%60.93%-3.81%13.79%4.72%-34.19%
Enterprise Value
404527312526
Last Close Price
1.652.041.511.571.652.28

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---113.47--
Forward PE
-1.121.121.121.121.12
PB Ratio
-54.94-29.13-125.746.72-462.92-23.37
P/TBV Ratio
---6.72--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
---99.84--
EV/EBIT Ratio
---203.31--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.02-0.04-0.120.01-75.33-6.43
Debt / EBITDA Ratio
---0.11--
Net Debt / Equity Ratio
4.381.508.66-1.3624.050.08
Net Debt / EBITDA Ratio
----20.530.190.01
Net Debt / FCF Ratio
0.580.420.321.390.160.01
Quick Ratio
2.602.894.013.383.262.89
Current Ratio
2.892.924.063.393.282.91
Return on Equity (ROE)
-1415.14%--220.33%12.00%--396.06%
Return on Assets (ROA)
-88.85%-152.57%-67.44%1.49%-71.39%-64.41%
Return on Capital Employed (ROCE)
-246.20%-364.30%-259.40%3.20%-184.60%-242.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.42%-13.47%-16.17%0.88%-33.41%-47.91%
FCF Yield
-13.81%-12.40%-21.43%-14.60%-32.05%-37.28%
Buyback Yield / Dilution
-12.25%-17.23%-17.25%-17.34%-43.59%-38.03%